CL2007003806A1 -
Compounds derived from n- (2h-pyrazol-3-yl) -amide, fgfr inhibitors; pharmaceutical composition comprising said compounds; its preparation process; and its use for the treatment of cancer.
- Google Patents
Compounds derived from n- (2h-pyrazol-3-yl) -amide, fgfr inhibitors; pharmaceutical composition comprising said compounds; its preparation process; and its use for the treatment of cancer.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=68342344&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007003806(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Publication of CL2007003806A1publicationCriticalpatent/CL2007003806A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
COMPUESTO DE FÓRMULA I, O UNA SAL FARMACÉUTICAMENTE ACEPTABLE DE ÉL. TAMBIÉN SE HAN PROVISTO PROCESOS PARA LA PRODUCCIÓN DE UN COMPUESTO DE LA FÓRMULA I Y EL USO DE UN COMPUESTO DE LA FÓRMULA I COMO UN MEDICAMENTO Y EN EL TRATAMIENTO DEL CÁNCER.COMPOSED OF FORMULA I, OR A PHARMACEUTICALLY ACCEPTABLE SALT OF IT. PROCESSES HAVE ALSO BEEN PROVIDED FOR THE PRODUCTION OF A COMPOUND OF FORMULA I AND THE USE OF A COMPOUND OF FORMULA I AS A MEDICINAL PRODUCT AND IN THE TREATMENT OF CANCER.
CL2007003806A2007-11-052007-12-21
Compounds derived from n- (2h-pyrazol-3-yl) -amide, fgfr inhibitors; pharmaceutical composition comprising said compounds; its preparation process; and its use for the treatment of cancer.
CL2007003806A1
(en)
Compounds derived from n- (2h-pyrazol-3-yl) -amide, fgfr inhibitors; pharmaceutical composition comprising said compounds; its preparation process; and its use for the treatment of cancer.
Phenylalanine derivative compounds; preparation process; pharmaceutical composition comprising said compound; and use of the compound as integrin inhibitors for the treatment of cancer.
NEW PIRIMIDINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PROCESSES FOR THEIR PREPARATION AND APPLICATIONS.
DERIVATIVES OF QUINOLINA 057; A PROCESS FOR PREPARATION; A PHARMACEUTICAL COMPOSITION; THE PREPARATION OF THIS AND THE USE OF THE COMPOUND TO PREPARE A MEDICINAL PRODUCT
NANOPARTICLES THAT INCLUDE A THYROSINE KINASE INHIBITOR RECEIVING THE GROWTH FACTOR DERIVED FROM PLATES; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF VASCULAR DISEASES, SUCH AS RESTENOSIS
COMPOUNDS DERIVED FROM 4-PHENYLAMINO-QUINOLINO-3-CARBOXAMIDA, INHIBITORS OF CSF-1R QUINASA; PREPARATION PROCESS; INTERMEDIATE COMPOUNDS INVOLVED IN THIS PROCESS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF CHEST TUMORS, PR